- All sections
- C - Chemistry; metallurgy
- C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; compositions or test papers therefor; processes of preparing such compositions; condition-responsive control in microbiological or enzymological processes
- C12Q 1/6816 - Hybridisation assays characterised by the detection means
Patent holdings for IPC class C12Q 1/6816
Total number of patents in this class: 1366
10-year publication summary
36
|
42
|
87
|
128
|
176
|
157
|
181
|
190
|
183
|
140
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
President and Fellows of Harvard College | 5838 |
70 |
Bio-Rad Laboratories, Inc. | 1597 |
40 |
Illumina, Inc. | 2890 |
36 |
Massachusetts Institute of Technology | 9834 |
34 |
10X Genomics, Inc. | 1011 |
31 |
The Broad Institute, Inc. | 1637 |
29 |
Roche Sequencing Solutions, Inc. | 583 |
28 |
Illumina Cambridge Limited | 679 |
19 |
The Regents of the University of California | 19150 |
18 |
Becton, Dickinson and Company | 6890 |
16 |
Seegene, Inc. | 340 |
15 |
Gen-Probe Incorporated | 982 |
14 |
Meso Scale Technologies, LLC | 367 |
14 |
Mammoth Biosciences, Inc. | 109 |
14 |
Life Technologies Corporation | 3126 |
13 |
The Board of Trustees of the Leland Stanford Junior University | 6111 |
12 |
Luminex Corporation | 309 |
12 |
Pacific Biosciences of California, Inc. | 746 |
12 |
The Chinese University of Hong Kong | 148 |
11 |
Binx Health Limited, FORMERLY Atlas Genetics Limited | 49 |
11 |
Other owners | 917 |